1
|
Price J, Pascoe A, Weston C, Kathirgamakarthigeyan S, Griffin M, Ganatra R, Christian J. EP-1065: Post-treatment FDG-PET CT in detecting residual disease in head & neck squamous cell carcinoma. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32315-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
2
|
Sehgal R, Saha S, Wiese D, Parker R, Huang W, Arora M, Doan K, Ganatra R, Yestrepsky B, Yee C, Patel M. P53 as a predictor of tumor burden in lymph nodes (LN) in colon cancer (Cca) patients (pts) undergoing sentinel lymph node (SLN) mapping (M). J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.3617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3617 Background: p53 and LN status(S) are important prognostic markers in Cca. Our study was done to evaluate whether p53 S could predict tumor burden in LNs in Cca undergoing SLNM. Methods: Pts with Cca underwent SLNM to determine the LN S. A portion of tumor was used for detection of p53 S by IHC.p53 Histo Score (HS) was defined as (Intensity of stain in cells from 0–4 +1) × (% cells staining). HS of 180 was taken as cut off for significance based on previous studies on solid tumors. Metastatic foci in SLNs and nonSLNs were measured in greatest diameter by ocular micrometer. For overall tumor burden in SLNs and nonSLNs,all metastatic foci were added for each pt. Results: SLNM was successful in 100% of the 117 consecutive pts with Cca. Pts with distant metastasis (mets) (18) and skip mets (9) were excluded. Of the remaining 90 pts,39% were SLN positive (+ve) and 61% were SLN negative (-ve). HS of ≤ 180 was found in 66% and HS >180 was found in 34% of the pts. In 55 SLN -ve pts 76% had HS ≤ 180 while 24% had HS >180. In 35 SLN +ve pts, 49% had HS of ≤ 180 and 51% had HS >180. ( Table ) Of SLN +ve pts, size of metastatic tumor in LNs was available in 86% of pts. Average (av.) non SLN met size was 0.95 cms in pts with HS ≤ 180 and 3.4 cms in pts with HS > 180. Av. SLN met size was 0.63 cms in pts with HS ≤ 180 and 0.9 cms in pts with HS>180 ( Table ). No statistical significance was found among T stage of pts with HS >180 vs ≤ 180. Conclusion: Pts with p53 HS >180 showed significantly greater tumor burden in both SLNs and non SLNs as compared to pts with HS ≤ 180. Also probability of having SLN -ve disease is higher in pts with HS ≤ 180 as compared to pts with HS >180 in Cca. Thus,even in SLN -ve pts, high HS may indicate a worse prognosis. Hence,a high p53 HS might predict pts with Cca having higher tumor burden in LNs and thus identify an aggressive subgroup of pts. [Table: see text] No significant financial relationships to disclose.
Collapse
Affiliation(s)
- R. Sehgal
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - S. Saha
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - D. Wiese
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - R. Parker
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - W. Huang
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - M. Arora
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - K. Doan
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - R. Ganatra
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - B. Yestrepsky
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - C. Yee
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| | - M. Patel
- McLaren Regional Medical Center, Flint, MI; Oncotech, Tustin, CA; Genesys Regional Medical Center, Grand Blanc, MI
| |
Collapse
|
3
|
Abstract
Primary malignant rhabdoid tumour of the central nervous system is a rare neoplasm affecting children. We present a pathologically proven case, which was initially referred to the paediatric surgeons as a sebaceous cyst, and highlights the importance of imaging prior to surgery of potentially innocuous scalp lesions. Imaging features on CT and MRI are presented, which show bony involvement not previously reported in the literature.
Collapse
Affiliation(s)
- A Evans
- Department of Radiology, University Hospital of Wales, Heath, Cardiff CFI4 4XN, UK
| | | | | |
Collapse
|
4
|
Ganatra R, Gembicki M, Nofal M. Optimization of nuclear medicine procedures for the diagnosis and management of thyroid disorders: report of a research coordination meeting held in Vienna, 15-17 December 1986 under the auspices of the International Atomic Energy Agency. Nucl Med Commun 1988; 9:131-9. [PMID: 3386976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
The third and final meeting of a coordinated research programme on the diagnosis and management of thyroid disorders was held in Vienna from 15 to 17 December 1986. The participants were from Czechoslovakia, Egypt, Israel, Malaysia and Thailand. Each participant had studied between 500 and 1000 patients for thyroid function evaluation by performing T3, T4 and TSH radioimmunoassays. Each had also used the newly available supersensitive immunoradiometric (IRMA) assay in a group of patients to compare the efficiency of the new assay with that of the conventional assay. A microcomputer was provided to each participant for data analysis. Internal quality control was studied by establishing precision profiles and external quality control was on the basis of pooled standard sera in different ranges. Recommendation for the strategy suggested T4 RIA as the test of first choice in each category of thyroid function. IRMA TSH was suggested as a second test in borderline cases.
Collapse
|